1. Data Is No Longer a Technical Layer. It Is a Strategic Asset.
For years, many healthcare software businesses treated data as a byproduct of workflow — something captured incidentally and structured later, once scale had been achieved. That approach no longer works.
As Alex Eavis notes:
“If you don’t design your data structure early, technical debt compounds quickly — and in healthcare, that becomes commercial debt.”
Poorly structured data can:
- Limit interoperability across providers
- Undermine research partnerships
- Reduce AI reliability
- Weaken regulatory confidence
- Complicate investor diligence
- Delay enterprise procurement
Healthcare founders must think beyond dashboards and storage. The strategic questions are:
- Is your data consistently coded and normalized?
- Do you have a semantic layer that enables reuse?
- Can you prove provenance and transformation logic?
- Does your architecture support structured and unstructured inputs
- Does your data improve in value over time?
Structured data enables scale and reproducibility. Unstructured data captures nuance and longitudinal context. The companies that win will design intentionally for both.
2. AI Fails for Organizational — Not Technical — Reasons.
The dominant narrative suggests AI success depends on model sophistication. In healthcare, that’s rarely true.
Most failures occur because:
- Data foundations are weak
- Governance is retrofitted
- Regulatory implications were underestimated
- Workflow integration was ignored
- Trust was not built
Dr Indra Joshi emphasizes:
“It’s rarely the tech that fails. It’s the people, process, and regulatory alignment that weren’t designed into deployment.”
Healthcare AI must embed monitoring, accountability, and regulatory awareness from day one. A pilot is not a product. Deployment requires organizational readiness.
Healthcare is uniquely regulated — and uniquely human. The primary goal of any clinician is not to use your AI. It is to care safely for the patient in front of them.
If your product introduces uncertainty rather than confidence, adoption will stall.
3. Trust Is the Real Differentiator.
In healthcare, trust is the product. Trust is built through:
- Data traceability (Where did it come from?)
- Model traceability (What version? Trained on what?)
- Decision traceability (Why this output?)
- Clear human oversight and accountability
AI governance is not friction. It is defensibility. Companies that embed transparency and regulatory alignment into their architecture from day one will build long-term competitive advantage.
4. Monetizing Data Without Losing Alignment.
The most sustainable models are not about selling raw data. They are about generating aligned intelligence. Viable approaches include:
- Intelligence layers that enhance decision-making for data owners
- Transparent value-share partnerships in research and life sciences
- Derivative analytics platforms built on aggregated datasets
The common thread is aligned incentives. When patients, providers, healthcare systems, and companies all benefit, value compounds.
5. What investors expect now.
The presence of AI is no longer impressive. It is expected. What matters instead is:
- A clear data strategy
- Regulatory maturity
- Embedded workflow positioning
- Evidence of trust capital
- Network effects in data
- Accumulated domain expertise codified into tooling.
At Upliift we do not expect founders to predict AI five years out. But we do want to see evidence of:
- A clear near-term AI roadmap
- A long-term industry positioning vision
- An understanding of how data creates defensibility.
The companies that endure will not chase hype cycles. They will build deep workflow integration and compounding trust.
6. Red flags CEOs should watch.
- AI cost-saving promises disconnected from process redesign
- Regulatory assumptions left vague
- Internal data hygiene ignored
- Governance added late
- Overconfidence in demos
- Underestimating healthcare complexity
Healthcare is one of the hardest verticals in software due to regulation. AI does not remove that complexity, instead it amplifies the advantage of companies built on strong foundations.
The Opportunity Ahead.
Healthcare founders have a rare opportunity. If you have built workflow depth, earned trust, invested in data architecture, embedded regulatory thinking, and codified domain expertise — AI becomes a multiplier. If not, it becomes noise.
Enterprise value in healthcare is not created by adding AI. It is created by integrating it intelligently into durable systems. The companies that understand this will define the next decade of healthcare technology.
About the Contributors
![]() |
![]() |
![]() |
| Sebastien Jacquemoud | Alex Eavis | Dr Indra Joshi |
| Healthcare Portfolio Director, Upliift. Seb works with founders of European healthcare software companies to scale strategically and create long-term enterprise value. He is co-author of The Founders Guide to AI. | Chief Product & Technology Officer, Genomics. Alex has built and scaled national healthcare data platforms including EMIS-X analytics spanning 35 million longitudinal records. | Chief Development Officer, Optum UK. Indra is the former founder of the NHS AI Lab and leader of the NHS Federated Data Platform covering 50 million secondary care records. |









